Treatment of Urinary Tract Infections in Pregnancy
For pregnant women with UTIs, first-line treatment should include nitrofurantoin, fosfomycin trometamol, or amoxicillin-clavulanate based on local antibiogram patterns, as these medications are both effective and safe during pregnancy. 1, 2, 3
Diagnostic Approach
- Obtain urine culture before initiating treatment to confirm diagnosis and guide therapy 1
- Do not screen for or treat asymptomatic bacteriuria in most populations, but pregnant women are an exception 1
- Screen for and treat asymptomatic bacteriuria in pregnant women with standard short-course treatment 1
First-Line Treatment Options for UTI in Pregnancy
Nitrofurantoin
- Dosing: 100 mg twice daily for 5 days
- Advantages: High urinary concentration, low resistance rates
- Caution: Avoid in G6PD deficiency and near term (>36 weeks)
Fosfomycin trometamol
- Dosing: 3 g single dose
- Advantages: Convenient single-dose regimen, high compliance
- Particularly effective for uncomplicated cystitis
Amoxicillin-clavulanate
- Dosing: 875/125 mg twice daily for 5-7 days
- Effective against beta-lactamase-producing E. coli and other common uropathogens
- Useful when resistance to first-line agents is suspected 2
Cephalosporins (e.g., cefixime)
- Alternative when first-line agents cannot be used
- Particularly useful when local resistance patterns indicate better coverage 3
Treatment Duration
- Asymptomatic bacteriuria: Single-dose fosfomycin or short course (3-5 days) of antibiotics
- Symptomatic lower UTI (cystitis): 5-7 days of antibiotics
- Pyelonephritis: 7-14 days of antibiotics, often starting with parenteral therapy 1
Special Considerations
Pyelonephritis in Pregnancy
- Requires hospitalization and initial parenteral antibiotics
- Options include:
- Ceftriaxone 1-2 g daily
- Amoxicillin-clavulanate with an aminoglycoside
- Switch to oral therapy when clinically improved 4
Recurrent UTIs in Pregnancy
- Post-coital prophylaxis with cephalexin (250 mg) or nitrofurantoin (50 mg) is highly effective 5
- For women with history of recurrent UTIs, prophylactic antibiotics significantly reduce recurrence risk during pregnancy 5
Follow-up
- Obtain follow-up urine culture 1-2 weeks after completing treatment to confirm cure
- Persistent bacteriuria requires retreatment with a different antibiotic based on susceptibility testing
Common Pitfalls to Avoid
- Failing to treat asymptomatic bacteriuria in pregnant women, which can lead to pyelonephritis and adverse pregnancy outcomes
- Using trimethoprim-sulfamethoxazole in the first or third trimester (contraindicated)
- Not obtaining pre-treatment cultures which are essential for confirming diagnosis and guiding therapy
- Inadequate follow-up after treatment, which may miss persistent infection
- Using fluoroquinolones which should be avoided during pregnancy due to potential fetal risks
By following this evidence-based approach to UTI management in pregnancy, clinicians can effectively treat infections while minimizing risks to both mother and fetus.